Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
AUTOR(ES)
Yarkoni, E
RESUMO
Emulsified cell walls of Mycobacterium bovis (BCG) were immunotherapeutically at least as active as living BCG in prolonging survival of guinea pigs with established dermal tumors and microscopic lymph node and visceral metastases.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=414338Documentos Relacionados
- Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally administered killed BCG cells and BCG cell walls.
- Immunotherapy of guinea pig line 10 hepatoma with nonliving BCG cells in aqueous medium.
- Regression by active specific immunotherapy of established dermal tumor transplants and lymph node metastases in guinea pigs.
- Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6′-Dimycolate) in Tumor Regression
- Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6,6′-Dimycolate) in Tumor Regression